Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 3Phase 1 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1Phase 3 1

Status

Completed 5Unknown 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 53Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Carcinoma, Non-Small-Cell Lung 17Prostatic Neoplasms 15Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 12Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Bone Neoplasms × Clear all
NCT02905916 2016-09-19

The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy

Peking University

Phase 4 Unknown
217 enrolled
BreastLymphoidSarcoma

Bone Neoplasms, Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡